June 16th 2025
Healthcare providers must enhance awareness of counterfeit medicines to protect patients, especially as online drug purchases rise.
May 28th 2025
This serialization system represents a business imperative that yields significant competitive advantages.
April 15th 2025
When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.
April 11th 2025
Why taking proactive steps—and combing the right data sources—is critical to informed decision-making in risk management.
April 9th 2025
Ensuring that essential treatments reach patients safely and efficiently is an increasing imperative in today's pharma landscape.
Even While Regulatory Mandates Slip Into the Future, Brand Protection Needs Remain
Drugmakers recalibrate anti-counterfeiting and serialization efforts
A Pitched Battle in Cardiovascular Drug Marketing
Mature product franchises and mixed clinical outcomes have not dissuaded pharma companies from expending marketing resources for cardiovascular disease treatment
Building an Alternative Distribution Model for Ultra-Orphan Diseases
Biopharmaceutical manufacturers turn to a direct-distribution model to leverage opportunities for cost-effective drug delivery and personalized health management services